The study was led by Shengzhi Sun of Capital Medical University in Beijing, China, alongside a team of international colleagues. Their findings arrive at a time when sleep health has ascended to the forefront of public health priorities, particularly in East Asia. In China, the National Health Commission has increasingly identified sleep quantity and quality as a pillar of national wellness, a focus that is reflected in the most recent 2026 China Sleep Health White Paper. That report highlights a growing crisis of sleep deprivation: while the average surveyed Chinese citizen currently manages about 6.97 hours of sleep per night, nearly a quarter of the population—approximately 23 percent—survives on less than 6 hours. Furthermore, the White Paper indicates that only 26 percent of respondents maintain a consistent sleep schedule, with sleep disturbances becoming more prevalent over time. For citizens and policymakers alike, understanding the precise mechanisms by which these patterns translate into disease risk has become a matter of urgent relevance.
Historically, the scientific community has struggled to map the relationship between specific sleep stages and health outcomes in large populations. This difficulty stems largely from the limitations of data collection; most large-scale studies have relied on self-reported sleep measures, which often correlate poorly with objective physiological assessments. People frequently overestimate how long they sleep or fail to accurately recall the frequency of nighttime awakenings. To overcome these hurdles, Sun and his team turned to the UK Biobank, a massive biomedical database and research resource that follows the health and genetics of half a million participants.
The researchers analyzed data from a subset of 95,559 UK Biobank participants who participated in an objective sleep study. These individuals wore wrist-worn accelerometers—high-tech motion sensors—for seven consecutive days and nights. To translate this motion data into meaningful biological information, the team employed a sophisticated deep-learning algorithm capable of distinguishing between different sleep stages, including Rapid Eye Movement (REM) sleep, deep sleep (also known as slow-wave sleep), and light sleep. This technology also allowed them to measure total sleep duration, wakefulness after sleep onset (WASO), and the degree of night-to-night sleep irregularity. By following these participants for a median period of 8.9 years and cross-referencing their sleep data with comprehensive health records, the researchers were able to test for associations across more than 1,000 distinct disease outcomes.
The results of this "phenome-wide association analysis" were striking, identifying 156 significant associations between sleep patterns and incident diseases after applying the rigorous Bonferroni correction to ensure statistical reliability. One of the most significant revelations concerned REM sleep, the stage of sleep typically associated with vivid dreaming and memory consolidation. The study found that greater amounts of REM sleep were associated with a significantly lower risk of 83 different diseases. For every interquartile range increase in REM sleep—approximately 47.6 minutes—the risk of heart failure dropped significantly, with a hazard ratio of 0.74. Even more profound were the links to brain health: higher REM sleep duration was associated with a hazard ratio of 0.54 for dementia and a remarkable 0.20 for Parkinson’s disease, suggesting a potentially protective role for REM sleep against neurodegeneration.
Deep sleep, the stage characterized by slow brain waves where the body performs much of its physical repair, also showed targeted benefits. Greater amounts of deep sleep were linked to a lower risk of seven specific conditions, most notably type 2 diabetes and major depressive disorder. These findings reinforce the idea that different stages of sleep serve different "maintenance" functions for the human body; while REM may be crucial for neurological and cardiovascular integrity, deep sleep appears vital for metabolic regulation and emotional stability.
Conversely, the study highlighted the dangers of fragmented and irregular sleep. Both sleep irregularity—where the timing of sleep shifts significantly from night to night—and increased wakefulness after sleep onset were linked to higher risks of several psychiatric and behavioral conditions, including anxiety disorders and substance use disorders. This suggests that the "stability" of sleep is a health metric in its own right, independent of how many total hours a person spends in bed.
When examining total sleep duration, the researchers discovered a non-linear, often U-shaped relationship with disease risk. For 86 different disease phenotypes, the risk was not a simple straight line; instead, the lowest risk for 69 of these conditions was precisely concentrated within a narrow window of 6 to 8 hours of sleep per night. For those falling outside this "Goldilocks zone," the clinical risks began to climb. The most vulnerable group identified in the study were those sleeping less than 5 hours per night. These individuals faced an elevated risk for 37 different conditions, highlighting a threshold of sleep deprivation that the body cannot easily compensate for.
The authors noted that these findings provide robust evidence for the 6-to-8-hour sleep duration as a fundamental health safeguard, particularly for middle-aged and older adults. They hypothesize that this specific duration is optimal because it likely allows for a more favorable distribution of sleep stages, ensuring the body receives the necessary "dose" of both REM and deep sleep. "Maintaining a sleep duration of 6-8 hours can effectively reduce the risk of multiple diseases, providing new insights for health promotion and preventive practice," the authors stated, emphasizing that sleep should be viewed as a modifiable risk factor in the same vein as diet and exercise.
Despite the breadth and statistical power of the study, the researchers were careful to note its limitations. Because it was an observational study, it can identify strong correlations but cannot definitively establish that specific sleep patterns directly cause or prevent disease. It is possible, for instance, that early-stage, undiagnosed disease might cause changes in sleep patterns, rather than the other way around. However, the use of objective accelerometer data and a nearly decade-long follow-up period lends significant weight to the associations found.
The technical depth of the study is further underscored by the sheer volume of data processed. By testing associations against more than 1,000 disease outcomes, the team provided one of the most comprehensive maps of the "sleep-disease landscape" ever produced. The identification of 156 significant associations after the Bonferroni correction—a statistical method used to reduce the chance of false positives when performing multiple tests—demonstrates the high level of confidence in these results.
This research was supported by several prestigious Chinese scientific institutions, including the National Science Fund for Distinguished Young Scholars, the Key Program of the National Natural Science Foundation of China, and the Beijing Outstanding Young Scientist Program, with funding awarded to the researcher identified as RC. The Chinese Institutes for Medical Research in Beijing also provided support through the Young Beijing Scholars Project. The study authors confirmed that the funders had no role in the design of the study, the collection and analysis of data, the decision to publish, or the preparation of the final manuscript.
As the global "sleep economy" grows and more people turn to wearable devices to track their rest, this study provides a scientific framework for interpreting that data. It moves the conversation beyond a simple "hours per night" metric and toward a more nuanced understanding of sleep architecture. For the millions of people who struggle with sleep consistency or duration, the message from Capital Medical University is clear: the time spent in REM and deep sleep is not merely "down time," but a period of active biological defense against a vast array of chronic illnesses. The findings suggest that public health initiatives aimed at improving sleep hygiene could have a profound impact on reducing the global burden of heart disease, diabetes, and neurodegenerative conditions.
